Aspirin toxicity for human colonic tumor cells results from necrosis and is accompanied by cell cycle arrest

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2772-2776

  Subbegowda, Roopa ^a   Frommel, Thomas O ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; LIPOCORTIN 5; NAPROXEN; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL CYCLE; CELL DEATH; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ASPIRIN; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DNA, NEOPLASM; FLOW CYTOMETRY; HT29 CELLS; HUMANS; NECROSIS; NEOPLASM PROTEINS; VINBLASTINE;

EID: 0032127342     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Greenwald, P., Kelloff, G. J., Boone, C. W., and McDonald, S. S. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomark. Prev., 4: 691-702, 1995.
3. Muto, T., Bussey, H. J. R., and Morson, B. C. The evolution of cancer of the colon and rectum. Cancer (Phila.), 36: 2251-2270, 1975.
4. Dubois, R. N., Giardiello, F. M., and Smalley, W. E. Nonsteroidal antiinflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol. Clin. North Am., 25: 773-791, 1996.
5. Bennett, A., Civier, A., Hensby, C. N., Melhuish, P. B., and Stamford, I. F. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut, 28: 315-318, 1987.
6. 2 by fixed macrophages in colonic carcinoma. Digestion, 47: 160-166, 1990.
7. Maier, J. A. M., Hla, T., and Maciag, H. Cyclooxygenase is an immediate-early response gene induced in interleukin-1 in human endothelial cells. J. Biol. Chem., 265: 10805-10808, 1990.
8. O'Banion, M. K., Winn, V. D., and Young D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory Cyclooxygenase. Proc. Natl. Acad. Sci. USA, 89: 4888-4892, 1992.
9. Dubois, R. N., Ysujii, M., Bishop, P., Awad, J. A., Makita, K., and Lanahan, A. Cloning and characterization of a growth factor-inducible cyclooxygenase from rat intestinal epithelial cells. Am. J. Physiol., 266: G822-G827, 1994.
10. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrebach, S., and Dubois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
11. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
12. Piazza, G. A., Kulchak Rahm, A. L., Krutzsch, M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., Pamukcu, R., and Ahnen, D. J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55: 3110-3116, 1995.
13. Elder, D. J. E., Hague, A., Hicks, D. J., and Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56: 2273-2276, 1996.
14. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1996.
15. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., and Schols, D. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods, 20: 309-321, 1988.
16. Andree, H. A. M., Reutelingsperger, C. P. M., Hauptmann, R., Hemker, H. C., Hermens, W. T., and Willems, G. M. Binding of vascular anticoagulant α (VACα) to planar phospholipid bilayers. J. Biol. Chem. 265: 4923-4928, 1990.
17. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. Exposure of phosphotidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207-2216, 1992.
18. Lee, I-M., Hennekens, C. H., and Buring, J. E. Use of aspirin and other nonsteroidal antiinflammatory drugs and the risk of cancer development. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 599-607. Philadelphia: Lippincott-Raven, 1997.
19. Marnett, L. J. Generation of mutagens during arachidonic acid metabolism. Cancer Metastasis Rev., 13: 303-308, 1994.
20. Young, M. R. I. Eicosanoids and the immunology of cancer. Cancer Metastasis Rev., 13: 337-348, 1994.
21. Kantor, H., and Hampton, M. Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase. Nature (Lond.), 276: 841-842, 1978.
22. 1 phase of the cell cycle by indomethacin. J. Pharmacol. Exp. Ther., 210: 106-111, 1979.
23. Abramson, S., Korchak, H., Ludewig, R., Edelson, H., Haines, K., Levin, R. L., Herman, R., Rider, L., Kimmel, S., and Weissman G. Modes of action of aspirin-like drugs. Proc. Natl. Acad. Sci. USA, 82: 7227-7231, 1985.
24. Abramson, S. B., Leszczynska-Piziak, J., Haines, K., and Reibman, J. Non-steroidal anti-inflammatory drugs: effects on a GTP binding protein within the neutrophil plasma membrane. Biochem. Pharmacol., 41: 1567-1573, 1991.
25. Kopp, E., and Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science (Washington DC), 265: 956-959, 1994.
26. Hixson, L. J., Alberts, D. S., Krutzsch, M., Einsphar, J., Brendel, K., Gross, P. H., Paranks, N. S., Baier, M., Emerson, S., Pamukcu, R., and Burt, R. W. Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol. Biomark. Prev., 3: 433-438, 1994.
27. Thompson, H. J., Briggs, S., Paranka, N. S., Piazza, G. A., Brendel, K., Gross, P., Sperl, G. J., Pamukcu, R., and Ahnen, D. J. Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J. Natl. Cancer Inst., 87: 1259-1260, 1995.
28. 4 production in human colonic mucosa from cancer patients. Clin. Cancer Res., 3: 209-213, 1997.
29. Demello, M. C. F., Bayer, B. M., and Beaven, M. A. Evidence that prostaglandins do not have a role in the cytostatic action of anti-inflammatory drugs. Biochem. Pharmacol., 29: 311-318, 1980.
30. Lu, X., Xie, W., Reed, D., Bradshaw, W. S., and Simmons, D. L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 7961-7965, 1995.
31. Shiff, S. J., Qiao, L., Tsai, L-L., and Rigas, B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest., 96: 491-503, 1995.
32. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., and Giardiello, F. M. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109: 994-998, 1995.
33. Shiff, S. J., Koutsos, M. I., Qiao, L., and Rigas, B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222: 179-188, 1996.